BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12521361)

  • 21. A comparison of cyclosporine assays using sequential samples from selected transplant patients.
    LeGatt DF; Coates JE; Simpson AI; Shalapay CE; Rintoul BJ; Yatscoff RW
    Clin Biochem; 1994 Feb; 27(1):43-8. PubMed ID: 8200114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring, of heart transplant recipients.
    Regazzi MB; Molinaro M; Tinelli C; D'Eril GM; Goggi C; Campana C; Fiorito V; Moratti R; Viganò M
    Ther Drug Monit; 2000 Dec; 22(6):712-5. PubMed ID: 11128239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoring.
    Morris RG
    Ther Drug Monit; 2000 Apr; 22(2):160-2. PubMed ID: 10774626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of four automated methods for determination of whole blood cyclosporine concentrations.
    Hamwi A; Veitl M; Männer G; Ruzicka K; Schweiger C; Szekeres T
    Am J Clin Pathol; 1999 Sep; 112(3):358-65. PubMed ID: 10478141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays.
    Yatscoff RW; Langman LJ; LeGatt DF
    Clin Chem; 1993 Jun; 39(6):1089-92. PubMed ID: 8504544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC.
    Schütz E; Svinarov D; Shipkova M; Niedmann PD; Armstrong VW; Wieland E; Oellerich M
    Clin Chem; 1998 Oct; 44(10):2158-64. PubMed ID: 9761250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporine in whole blood after kidney, heart, and liver transplantation.
    Winkler M; Schumann G; Petersen D; Oellerich M; Wonigeit K
    Clin Chem; 1992 Jan; 38(1):123-6. PubMed ID: 1733584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EMIT cyclosporine assay: development of an application protocol for Technicon AXON System.
    LeGatt DF; Chooi M; Simpson AI; Yatscoff RW
    Clin Biochem; 1994 Oct; 27(5):387-94. PubMed ID: 7867217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 2. Cross-reactivity of the antisera with cyclosporine metabolites.
    Lensmeyer GL; Wiebe DA; Carlson IH; deVos DJ
    Clin Chem; 1990 Jan; 36(1):119-23. PubMed ID: 2297901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry for Cyclosporine Analysis in Human Whole Blood and Comparison With an Antibody-Conjugated Magnetic Immunoassay.
    Mei S; Wang J; Chen D; Zhu L; Zhao M; Hu X; Yang L; Zhao Z
    Ther Drug Monit; 2018 Feb; 40(1):69-75. PubMed ID: 29206806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of three methods for cyclosporine therapeutic monitoring.
    Jebabli N; Klouz A; Bahlous A; Gaïes E; Trabelsi S; Lakhal M; Belkahia C
    Transplant Proc; 2007 Oct; 39(8):2557-9. PubMed ID: 17954172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of EMIT Cyclosporine Assay for use with whole blood.
    Beresini MH; Davalian D; Alexander S; Toton-Quinn R; Barnett B; Cerelli MJ; Hu MW; Berger DE; Blohm WP; Jaklitsch A
    Clin Chem; 1993 Nov; 39(11 Pt 1):2235-41. PubMed ID: 8222215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 1. Results with patients' specimens.
    Strassman MJ; Lensmeyer GL; Wiebe DA; Carlson IH
    Clin Chem; 1990 Jan; 36(1):115-8. PubMed ID: 2297900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of automated ACMIA and EMIT immunoassays for whole blood cyclosporin monitoring.
    Dessars B; Cotton F; Thiry P; Gulbis B
    Clin Lab; 2003; 49(3-4):135-40. PubMed ID: 12705695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation.
    Cattaneo D; Zenoni S; Murgia S; Merlini S; Baldelli S; Perico N; Gotti E; Ottomano C; Crippa A; Remuzzi G
    Clin Chim Acta; 2005 May; 355(1-2):153-64. PubMed ID: 15820490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole blood cyclosporin monitoring in liver and heart transplant patients: evaluation of the specificity of a fluorescence polarization immunoassay and an enzyme-multiplied immunoassay technique.
    Gulbis B; Van der Heijden J; van As H; Thiry P
    J Pharm Biomed Anal; 1997 Apr; 15(7):957-63. PubMed ID: 9160262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay.
    Mei S; Wang J; Chen D; Zhu L; Zhao M; Tian X; Hu X; Zhao Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1087-1088():36-42. PubMed ID: 29704799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the new AxSYM cyclosporine assay: comparison with TDx monoclonal whole blood and Emit cyclosporine assays.
    Wallemacq PE; Alexandre K
    Clin Chem; 1999 Mar; 45(3):432-5. PubMed ID: 10053055
    [No Abstract]   [Full Text] [Related]  

  • 39. Variability of cyclosporine concentrations by HPLC and TDX monoclonal assay methods, application of a correction factor, and description of a novel clinical approach to determine the practical consequences of changing assay technique.
    Trifilio SM; Scheetz M; Borensztajn J; Mehta J
    Clin Transplant; 2013; 27(1):154-61. PubMed ID: 23106694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A preliminary study to evaluate an in vitro assay for determining patient whole blood immunosuppressive cyclosporine A and metabolite activity: comparison with cytosolic binding assays using cyclophilin or a 50-kilodalton binding protein, and the Abbott TDx cyclosporine A parent, and parent and metabolites assays.
    Russell RL; Donnelly JG; Palaszynski EW; Chan MM; Soldin SJ
    Ther Drug Monit; 1991 Jan; 13(1):32-6. PubMed ID: 1829283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.